Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
Brown, Nicholas, McBain, Catherine, Nash, Stephen, Hopkins, Kirsten, Sanghera, Paul, Saran, Frank, Phillips, Mark, Dungey, Fiona, Clifton-Hadley, Laura, Wanek, Katharina, Krell, Daniel, Jeffries, Sarah, Khan, Iftekhar, Smith, Paul, Mulholland, Paul
Published in PloS one (27.05.2016)
Published in PloS one (27.05.2016)
Get full text
Journal Article
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients
Hexter, Adam, Jones, Adrian, Joe, Harry, Heap, Laura, Smith, Miriam J, Wallace, Andrew J, Halliday, Dorothy, Parry, Allyson, Taylor, Amy, Raymond, Lucy, Shaw, Adam, Afridi, Shazia, Obholzer, Rupert, Axon, Patrick, King, Andrew T, Friedman, Jan M, Evans, D Gareth R
Published in Journal of medical genetics (01.10.2015)
Published in Journal of medical genetics (01.10.2015)
Get full text
Journal Article
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial
Brazil, Lucy, Swampillai, Angela L, Mak, Ka Man, Edwards, Darren, Mesiri, Pavlina, Clifton-Hadley, Laura, Shaffer, Richard, Lewis, Joanne, Watts, Colin, Jeffries, Sarah, Gkogkou, Pinelopi, Chalmers, Anthony J, Fersht, Naomi L, Hackshaw, Allan, Short, Susan C
Published in Neuro-oncology advances (01.01.2020)
Published in Neuro-oncology advances (01.01.2020)
Get full text
Journal Article
AT-43MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND PHASE II STUDY COMPARING CEDIRANIB (AZD2171) PLUS GEFITINIB (IRESSA, ZD1839) WITH CEDIRANIB PLUS PLACEBO IN SUBJECTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
Mulholland, Paul, Krell, Daniel, Khan, Iftekhar, McBain, Catherine, Patel, Chaya, Wanek, Katharina, Hopkins, Kirsten, Jeffries, Sarah, Jager, Rolf, Smith, Paul, Liu, Qi, Stupp, Roger, Tomlinson, Ian
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Get full text
Journal Article
AT-43 MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND PHASE II STUDY COMPARING CEDIRANIB (AZD2171) PLUS GEFITINIB (IRESSA, ZD1839) WITH CEDIRANIB PLUS PLACEBO IN SUBJECTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
Mulholland, P., Krell, D., Khan, I., McBain, C., Patel, C., Wanek, K., Hopkins, K., Jeffries, S., Jager, R., Smith, P., Liu, Q., Stupp, R., Tomlinson, I.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Get full text
Journal Article